Lifestance Health [LFST] vs DaVita [DVA] Detailed Stock Comparison
Lifestance Health
NASDAQ
Loading...
DaVita
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Lifestance Health wins in 4 metrics, DaVita wins in 14 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lifestance Health | DaVita | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -37.00 | 13.55 | Lifestance Health |
| Price-to-Book Ratio | 1.47 | 6.86 | Lifestance Health |
| Debt-to-Equity Ratio | 32.18 | 825.19 | Lifestance Health |
| PEG Ratio | 0.44 | 5.78 | Lifestance Health |
| EV/EBITDA | 41.49 | 8.87 | DaVita |
| Profit Margin (TTM) | -1.23% | 6.35% | DaVita |
| Operating Margin (TTM) | -0.85% | 15.70% | DaVita |
| EBITDA Margin (TTM) | N/A | 15.70% | N/A |
| Return on Equity | -1.11% | 57.94% | DaVita |
| Return on Assets (TTM) | 0.04% | 7.15% | DaVita |
| Free Cash Flow (TTM) | $85.69M | $1.47B | DaVita |
| 1-Year Return | -10.19% | -8.85% | DaVita |
| Price-to-Sales Ratio (TTM) | 1.64 | 0.75 | DaVita |
| Enterprise Value | $2.44B | $23.84B | DaVita |
| EV/Revenue Ratio | 1.86 | 1.81 | DaVita |
| Gross Profit Margin (TTM) | 31.40% | 33.08% | DaVita |
| Revenue per Share (TTM) | $3 | $164 | DaVita |
| Earnings per Share (Diluted) | $-0.04 | $10.15 | DaVita |
| Beta (Stock Volatility) | 1.13 | 1.09 | DaVita |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lifestance Health vs DaVita Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lifestance Health | 0.91% | 2.02% | 32.14% | -1.42% | -26.88% | -26.49% |
| DaVita | 2.02% | 3.68% | -3.90% | 1.33% | -1.18% | -6.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lifestance Health | -10.19% | -15.14% | -76.88% | -76.88% | -76.88% | -76.88% |
| DaVita | -8.85% | 58.33% | 61.44% | 83.98% | 328.97% | 530.26% |
Performance & Financial Health Analysis: Lifestance Health vs DaVita
| Metric | LFST | DVA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.16B | $9.84B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,662,190 | 705,370 |
| 90 Day Avg. Volume | 2,999,970 | 824,027 |
| Last Close | $5.55 | $140.36 |
| 52 Week Range | $3.74 - $8.61 | $126.07 - $179.60 |
| % from 52W High | -35.54% | -21.85% |
| All-Time High | $29.81 (Jul 05, 2021) | $179.60 (Jan 27, 2025) |
| % from All-Time High | -81.38% | -21.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.06% |
| Quarterly Earnings Growth | N/A | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.06% |
| Operating Margin (TTM) | -0.01% | 0.16% |
| Return on Equity (TTM) | -0.01% | 0.58% |
| Debt to Equity (MRQ) | 32.18 | 825.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.79 | $-4.98 |
| Cash per Share (MRQ) | $0.49 | $10.34 |
| Operating Cash Flow (TTM) | $146.34M | $1.86B |
| Levered Free Cash Flow (TTM) | $121.32M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Lifestance Health vs DaVita
| Metric | LFST | DVA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -37.00 | 13.55 |
| Forward P/E | -32.65 | 12.21 |
| PEG Ratio | 0.44 | 5.78 |
| Price to Sales (TTM) | 1.64 | 0.75 |
| Price to Book (MRQ) | 1.47 | 6.86 |
| Market Capitalization | ||
| Market Capitalization | $2.16B | $9.84B |
| Enterprise Value | $2.44B | $23.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.86 | 1.81 |
| Enterprise to EBITDA | 41.49 | 8.87 |
| Risk & Other Metrics | ||
| Beta | 1.13 | 1.09 |
| Book Value per Share (MRQ) | $3.79 | $-4.98 |
Financial Statements Comparison: Lifestance Health vs DaVita
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LFST | DVA |
|---|---|---|
| Revenue/Sales | $332.97M | $3.22B |
| Cost of Goods Sold | $223.18M | $2.24B |
| Gross Profit | $109.79M | $983.87M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.60M | $433.33M |
| EBITDA | $15.36M | $597.84M |
| Pre-Tax Income | $-1.47M | $286.33M |
| Income Tax | $-2.18M | $54.12M |
| Net Income (Profit) | $709,000 | $232.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LFST | DVA |
|---|---|---|
| Cash & Equivalents | $134.34M | $438.78M |
| Total Current Assets | $304.63M | $3.64B |
| Total Current Liabilities | $207.39M | $2.91B |
| Long-Term Debt | $425.71M | $11.72B |
| Total Shareholders Equity | $1.46B | $1.66B |
| Retained Earnings | $-817.58M | $1.70B |
| Property, Plant & Equipment | $148.91M | $11.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LFST | DVA |
|---|---|---|
| Operating Cash Flow | $23.35M | $287.94M |
| Capital Expenditures | $-7.17M | $-143.26M |
| Free Cash Flow | $-10.26M | $36.75M |
| Debt Repayment | $-1.81M | $-345.97M |
| Common Stock Repurchase | N/A | $-541.85M |
Short Interest & Institutional Ownership Analysis
| Metric | LFST | DVA |
|---|---|---|
| Shares Short | 7.41M | 6.11M |
| Short Ratio | 3.10 | 8.22 |
| Short % of Float | 0.09% | 0.16% |
| Average Daily Volume (10 Day) | 3,662,190 | 705,370 |
| Average Daily Volume (90 Day) | 2,999,970 | 824,027 |
| Shares Outstanding | 382.74M | 80.54M |
| Float Shares | 140.04M | 35.70M |
| % Held by Insiders | 0.08% | 0.50% |
| % Held by Institutions | 0.92% | 0.52% |
Dividend Analysis & Yield Comparison: Lifestance Health vs DaVita
| Metric | LFST | DVA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |